English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

Zhifei Biological Approved to Begin Phase III Trial of TB Vaccine

Jan. 10, 2013

Chongqing Zhifei Biological announced on January 11, 2013 that it was granted SFDA approval to begin a Phase III trial for its Mycobacterium Vaccae for injection (Vaccae). The product will be tested in clinical trials for the prevention of tuberculosis.